title: Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.
abstract: A new class of fungal biofilm inhibitors represented by shearinines D (3) and E (4) were obtained from a Penicillium sp. isolate. The inhibitory activities of 3 and 4 were characterized using a new imaging flow-cytometer technique, which enabled the rapid phenotypic analysis of Candida albicans cell types (budding yeast cells, germ tube cells, pseudohyphae, and hyphae) in biofilm populations. The results were confirmed by experimental data obtained from three-dimensional confocal laser scanning microscopy and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assays. These data indicate that 3 and 4 inhibited C. albicans biofilm formation by blocking the outgrowth of hyphae at a relatively late stage of biofilm development (IC50 = 8.5 and 7.6 μM, respectively). However, 3 and 4 demonstrated comparatively weak activity at disrupting existing biofilms. Compounds 3 and 4 also exhibited synergistic activities with amphotericin B against C. albicans and other clinical Candida isolates by enhancing the potency of amphotericin B up to 8-fold against cells in both developing and established biofilms. These data suggest that the Candida biofilm disruption and amphotericin B potentiating effects of 3 and 4 could be mediated through multiple biological targets. The shearinines are good tools for testing the potential advantages of using adjunctive therapies in combination with antifungals.
authors: Natural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Stephenson Life Sciences Research Center, 101 Stephenson Parkway, University of Oklahoma, Norman, OK 73019-5251, USA.
authors: Jianlan
authors: J
authors: You
authors: Lin
authors: L
authors: Du
authors: Jarrod B
authors: JB
authors: King
authors: Brian E
authors: BE
authors: Hall
authors: Robert H
authors: RH
authors: Cichewicz
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D018441:Biofilms; D002176:Candida albicans / Q000187:drug effects* / Q000502:physiology; D004357:Drug Synergism; D026121:Indole Alkaloids / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D018613:Microscopy, Confocal; D054852:Small Molecule Libraries
chemical_list: D000935:Antifungal Agents; D026121:Indole Alkaloids; D054852:Small Molecule Libraries; D000666:Amphotericin B
references: Mech Ageing Dev. 2011 Jun-Jul;132(6-7):315-23
references: 21736893
references: Open Microbiol J. 2011;5:119-26
references: 22207890
references: J Nat Prod. 2012 Mar 23;75(3):311-35
references: 22316239
references: PLoS Pathog. 2010 Mar 26;6(3):e1000828
references: 20360962
references: Int J Infect Dis. 2010 Nov;14(11):e954-66
references: 20797887
references: PLoS Pathog. 2011 Jul;7(7):e1002121
references: 21829345
references: Microbiology (Reading). 2010 Dec;156(Pt 12):3635-3644
references: 20705667
references: J Med Microbiol. 2012 Jan;61(Pt 1):109-114
references: 21903824
references: Antimicrob Agents Chemother. 2010 Jan;54(1):39-44
references: 19841146
references: J Clin Microbiol. 2007 Jun;45(6):1843-50
references: 17460052
references: J Med Microbiol. 2013 Jan;62(Pt 1):10-24
references: 23180477
references: Org Biomol Chem. 2012 Mar 14;10(10):2044-50
references: 22281750
references: J Clin Microbiol. 2011 Apr;49(4):1426-33
references: 21227984
references: PLoS One. 2011;6(9):e25395
references: 21966518
references: Cytometry A. 2008 Sep;73(9):825-33
references: 18613038
references: FEMS Yeast Res. 2006 Nov;6(7):979-86
references: 17042747
references: Appl Environ Microbiol. 2002 Nov;68(11):5459-63
references: 12406738
references: Nat Rev Microbiol. 2011 Feb;9(2):109-18
references: 21189476
references: Antimicrob Agents Chemother. 2006 Nov;50(11):3839-46
references: 16923951
references: Clin Microbiol Rev. 2007 Jan;20(1):133-63
references: 17223626
references: Microbes Infect. 2009 Jul-Aug;11(8-9):753-61
references: 19409507
references: Annu Rev Microbiol. 2010;64:357-72
references: 20528688
references: Mycoses. 2009 May;52(3):197-205
references: 19391253
references: J Nat Prod. 2007 Mar;70(3):461-77
references: 17309302
references: J Hosp Infect. 2003 Nov;55(3):159-68; quiz 233
references: 14572481
references: J Med Microbiol. 2009 Jun;58(Pt 6):779-790
references: 19429755
references: PLoS One. 2012;7(3):e33705
references: 22479431
references: Rev Iberoam Micol. 2009 Dec 31;26(4):223-7
references: 19836985
references: Methods Mol Med. 2005;118:143-52
references: 15888940
references: Eukaryot Cell. 2003 Jun;2(3):398-410
references: 12796285
references: Clin Microbiol Rev. 2004 Apr;17(2):255-67
references: 15084500
references: Drug Resist Updat. 2004 Aug-Oct;7(4-5):301-9
references: 15533767
references: J Nat Prod. 2012 Apr 27;75(4):707-15
references: 22400916
references: Tetrahedron Lett. 2012 Aug 8;53(32):4202-4205
references: 22844162
references: J Med Microbiol. 2006 Aug;55(Pt 8):999-1008
references: 16849719
references: Curr Opin Microbiol. 2011 Aug;14(4):380-5
references: 21741878
references: PLoS Pathog. 2007 Feb;3(2):e18
references: 17274686
references: Nat Protoc. 2008;3(12):1909-24
references: 19180075
references: J Hosp Infect. 2010 Sep;76(1):46-51
references: 20382444
references: J Formos Med Assoc. 2009 Jun;108(6):443-51
references: 19515624
references: Antimicrob Agents Chemother. 2002 Nov;46(11):3634-6
references: 12384379
references: Eukaryot Cell. 2011 Aug;10(8):1004-12
references: 21642508
references: Trends Microbiol. 2003 Jan;11(1):30-6
references: 12526852
references: Trends Microbiol. 2011 Nov;19(11):557-63
references: 21855346
references: Eukaryot Cell. 2011 Dec;10(12):1660-9
references: 21666076
references: J Infect Dis. 2010 Jul 1;202(1):171-5
references: 20497051